In broad clinical terms, there are four subtypes of breast cancer that solicit distinct treatment approaches: triple-negative tumors, HER2 positive tumors and two types of ER-positive breast cancers (Curigliano et al., 2017). Here, ESR1 is linked to breast cancer.